[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341246-105":59,"doc-detail-341246-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","neoantigen-identification-and-dendritic-cell-based-vaccines-for-lung-cancer-immunotherapy","Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy","","Immunotherapy offers durable benefit for difficult lung cancer, where limited options remain despite advances in surgery, radiation, and chemotherapy. Tumor-specific antigens are hard to discover, while neoantigens derived from genetic mutations, RNA splicing abnormalities, protein changes, or viral sequences act as non-self targets that can drive immune activation. Next-generation sequencing and bioinformatics enable rapid detection and prediction of highly immunogenic neoantigens, supporting personalized or generalized cancer immunotherapies. Dendritic cell vaccines are presented as stable, reliable, and safe candidates, with the article assessing current status, limitations, and future clinical use, including key MHC class I/II gene identification.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/neoantigen-identification-and-dendritic-cell-based-vaccines-for-lung-cancer-immunotherapy/341246/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/neoantigen-identification-and-dendritic-cell-based-vaccines-for-lung-cancer-immunotherapy/341246.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"What role do dendritic cells play in these vaccines?","Question",{"text":112,"@type":113},"Dendritic cells originate and regulate T-cell responses and are studied as immunotherapeutic agents. DC vaccines are described as stable, reliable, and safe in clinical trials, with emphasis on DC biology and manipulation.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},341246,1790147231,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":137,"preview_page_count":19,"preview_urls":138},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Review  \nNeoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy  \nKomal Kumari 1, Amarnath Singh 2, Archana Chaudhary 1, Rakesh Kumar Singh 3, Asheesh Shanker 4, Vinay Kumar 5 and Rizwanul Haque 1, *  \nCitation: Kumari, K.; Singh, A.; Chaudhary, A.; Singh, R.K.; Shanker, A.; Kumar, V.; Haque, R. Neoantigen Identification and Dendritic  \nCell-Based Vaccines for Lung Cancer Immunotherapy. Vaccines 2024, 12, 498. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)vaccines12050498  \nAcademic Editor: Subbaya Subramanian  \nReceived: 31 March 2024  \nRevised: 29 April 2024  \nAccepted: 1 May 2024  \nPublished: 5 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Biotechnology, Central University of South Bihar, Gaya 824236, Bihar, India; [komal@cusb.ac.in](komal@cusb.ac.in) (K.K.); [archana7893@gmail.com](archana7893@gmail.com) (A.C.)  \n2 Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; [amarrnath.singh@osumc.edu](amarrnath.singh@osumc.edu)  \n3 Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi 221005, Uttar Pradesh, India; [rakesh_bc@bhu.ac.in](rakesh_bc@bhu.ac.in)  \n4 Department of Bioinformatics, Central University of South Bihar, Gaya 824236, Bihar, India  \n5 Heart and Vascular Institute, Pennsylvania State University, Hershey Medical Center, Hershey, PA 17033, USA; [vinayktyagi07@gmail.com](vinayktyagi07@gmail.com)  \n* Correspondence: [rhaque@cub.ac.in](rhaque@cub.ac.in)  \nAbstract: Immunotherapies can treat many cancers, including difficult-to-treat cases such as lung cancer. Due to its tolerability, long-lasting therapeutic responses, and efficacy in a wide spectrum of patients, immunotherapy can also help to treat lung cancer, which has few treatment choices. Tumor-specific antigens (TSAs) for cancer vaccinations and T-cell therapies are difficult to discover. Neoantigens (NeoAgs) from genetic mutations, irregular RNA splicing, protein changes, or viral genetic sequences in tumor cells provide a solution. NeoAgs, unlike TSAs, are non-self and can cause an immunological response. Next-generation sequencing (NGS) and bioinformatics can swiftly detect and forecast tumor-specific NeoAgs. Highly immunogenic NeoAgs provide personalized or generalized cancer immunotherapies. Dendritic cells (DCs), which originate and regulate T-cell responses, are widely studied potential immunotherapeutic therapies for lung cancer and other cancers. DC vaccines are stable, reliable, and safe in clinical trials. The purpose of this article is to evaluate the current status, limitations, and prospective clinical applications of DC vaccines, as well as the identification and selection of major histocompatibility complex (MHC) class I and II genes for NeoAgs. Our goal is to explain DC biology and activate DC manipulation to help researchers create extremely potent cancer vaccines for patients.  \nKeywords: tumor-specific antigens; dendritic cells; neoantigens; next-generation sequencing; lung cancer  \n1. Introduction  \nCancer ranks as one of the primary causes of both incidence and mortality in the current era. In 2020, the number of new cancer cases worldwide was 18 . 1 million, and approximately 9.5 million deaths were attributed to cancer. Projections indicate that these figures will rise to 29.5 million new cases and 16.4 million cancer-related deaths by 2040 [1] . According to GLOBOCAN 2020 estimates, lung cancer was the second greatest cause of both cancer-related incidence (11.4%; N = 2,206,771) and death (18.0%; N = 1,796,144) in 2020 [1] . Non-small cell lung cancer (NSCLC) and small cell ","cbCairyebNS6Impj","https://ap.wps.com/l/cbCairyebNS6Impj","pdf",1614394,26,"English","# Abstract\n# Introduction\n## Lung cancer burden and current therapies\n## Cancer immunotherapies and cancer vaccines\n## Tumor antigens: TAAs vs TSAs\n# Article Focus and Goals","[{\"question\":\"What role do dendritic cells play in these vaccines?\",\"answer\":\"Dendritic cells originate and regulate T-cell responses and are studied as immunotherapeutic agents. DC vaccines are described as stable, reliable, and safe in clinical trials, with emphasis on DC biology and manipulation.\"}]","Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy | PDF",1790041111,66,[139,143,147,151],{"page_no":8,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47f55ca77bb2e5c233550fc6eb3f09e3.webp",983,1390,{"page_no":14,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5100070b593e6835e48bea6e2c7170bc.webp",982,1388,{"page_no":81,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/808e7bb6d75442d18c762b80f9523652.webp",981,1387,{"page_no":19,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2504ae10c0a5225fc4477ad085026bc.webp",980,1385]